Dr Richard K Huffaker, DO | |
537 Sw Union Ave, Grants Pass, OR 97527-5543 | |
(541) 507-2150 | |
(541) 507-2151 |
Full Name | Dr Richard K Huffaker |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 18 Years |
Location | 537 Sw Union Ave, Grants Pass, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841498300 | NPI | - | NPPES |
500645491 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | DO157588 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Asante Three Rivers Medical Center | Grants pass, OR | Hospital |
Fairchild Medical Center | Yreka, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Asante Physician Partners | 8325206246 | 229 |
News Archive
New research suggests that antibiotic treatment could be asymptomatically inducing the transmission of the healthcare-acquired infection, C. difficile, contributing to the outbreaks that have recently been widely reported in hospitals and other settings. A team of scientists have successfully mirrored the infection cycle of C. difficile by generating a 'mouse hospital' with conditions mimicking the human environment in which C. difficile is transmitted.
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve outcomes of heart attacks and other major cardiovascular disease events in other settings, according to a new Northwestern Medicine study published in the Journal of the American Medical Association.
Researchers have identified a one-of-a kind mutation in the DNA of a patient who died of transthyretin (TTR) amyloidosis, a progressive condition characterized by the buildup of abnormal deposits of a misfolded protein called amyloid in the body's organs and tissues.
GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US.
› Verified 1 days ago
Entity Name | Asante Physician Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922381326 PECOS PAC ID: 8325206246 Enrollment ID: O20120223000671 |
News Archive
New research suggests that antibiotic treatment could be asymptomatically inducing the transmission of the healthcare-acquired infection, C. difficile, contributing to the outbreaks that have recently been widely reported in hospitals and other settings. A team of scientists have successfully mirrored the infection cycle of C. difficile by generating a 'mouse hospital' with conditions mimicking the human environment in which C. difficile is transmitted.
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve outcomes of heart attacks and other major cardiovascular disease events in other settings, according to a new Northwestern Medicine study published in the Journal of the American Medical Association.
Researchers have identified a one-of-a kind mutation in the DNA of a patient who died of transthyretin (TTR) amyloidosis, a progressive condition characterized by the buildup of abnormal deposits of a misfolded protein called amyloid in the body's organs and tissues.
GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Richard K Huffaker, DO 2825 E Barnett Rd, Mss, Medford, OR 97504-8332 Ph: (541) 789-4281 | Dr Richard K Huffaker, DO 537 Sw Union Ave, Grants Pass, OR 97527-5543 Ph: (541) 507-2150 |
News Archive
New research suggests that antibiotic treatment could be asymptomatically inducing the transmission of the healthcare-acquired infection, C. difficile, contributing to the outbreaks that have recently been widely reported in hospitals and other settings. A team of scientists have successfully mirrored the infection cycle of C. difficile by generating a 'mouse hospital' with conditions mimicking the human environment in which C. difficile is transmitted.
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve outcomes of heart attacks and other major cardiovascular disease events in other settings, according to a new Northwestern Medicine study published in the Journal of the American Medical Association.
Researchers have identified a one-of-a kind mutation in the DNA of a patient who died of transthyretin (TTR) amyloidosis, a progressive condition characterized by the buildup of abnormal deposits of a misfolded protein called amyloid in the body's organs and tissues.
GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US.
› Verified 1 days ago
Dr. Paul Elvin Johnson Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1600 Nw 6th St, Grants Pass, OR 97526 Phone: 541-476-7775 | |
Dr. Richard Cohen, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1600 Nw 6th St, Grants Pass, OR 97526 Phone: 541-476-7775 Fax: 541-476-3572 | |
Colleen M Lennard, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 537 Union Ave Fl 2, Grants Pass, OR 97527 Phone: 541-507-2150 | |
Dr. Daniel R Fear, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 537 Sw Union Ave, Second Floor, Grants Pass, OR 97527 Phone: 541-476-7775 Fax: 541-476-3572 | |
Mason Hinchcliff, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 537 Union Ave, Grants Pass, OR 97527 Phone: 541-507-2150 |